The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes

Diabetic Medicine

Volumn 22, Issue 9, 2005, Pages 1167-1172

  Canani, L H ^a   Costa, L A ^a   Crispim, D ^a   Goncalves Dos Santos K ^a   Roisenberg, I ^a   Lisboa H R K ^b   Sarturi Tres, G ^b   Maia, A L ^a   Gross, Jorge Luiz ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF PASSO FUNDO   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Angiotensin converting enzyme; Diabetes mellitus; Diabetic nephropathy; DNA polymorphism; Genetic predisposition

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CONFIDENCE INTERVAL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RISK FACTOR; URINALYSIS; URINARY EXCRETION;

ALBUMINURIA; ALLELES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 24044517187     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01622.x     Document Type: Article

References (19)

1. Krolewski AS, Ng DP, Canani LH, Warram JH. Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv Nephrol Necker Hosp 2001; 31: 295-315.
2. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000; 49: 1057-1063.
3. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998; 41: 47-53.
4. Kennon B, Petrie JR, Small M, Connell JM. Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 1999; 16: 448-458.
5. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M et al. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388.
6. Ueda S, Elliott HL, Morton JJ, Connell JM. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25: 1266-1269.
7. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A et al. Angiotensin I-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-664.
8. Canani LH, Gerchman F, Gross JL. Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy. Diabetes Care 1998; 21: 1545-1550.
9. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997; 20: 516-519.
10. Sambrock J, Fritsch EF, Mariatis T. Molecular Cloning-A Manual Laboratory. Cold Spring Harbor: Cold Spring Harbor Laboratory 1990.
11. de Azevedo MJ, Dalmaz CA, Caramori ML, Pecis M, Esteves JF, Maia AL et al. ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective study. J Diabetes Complications 2002; 16: 255-262.
12. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 1995; 9: 272-276.
13. Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N et al. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med 2003; 20: 677-682.
14. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997; 52: 473-477.
15. Ringel J, Beige J, Kunz R, Distler A, Sharma AM. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997; 40: 193-199.
16. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E, Diabetic Nephropathy Study Group. Excess of DD homozygotes in haemodialysed patients with type II diabetes. Nephrol Dial Transplant 1997; 12: 427-429.
17. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002; 51: 1655-1662.
18. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
19. Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 2002; 51: 1188-1193.